"If India counters with its own tariffs, it could disrupt supply chains, increase costs, and slow market expansion for both ...

In the world of chemistry, some reactions are too slow or too difficult and require the assistance of metals that act as ...

The announcement that 23andMe is filing for bankruptcy and has put its genetic genealogy database up for sale has sent its ...

One includes $25 million in upfront payment and up to $725 million worth of milestones; and the other $20 million upfront and $580 million in milestones, according to a Google translation of the ...

Mashable is a global, multi-platform media and entertainment company.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Dexcom (DXCM – Research Report) and Amgen (AMGN – Research ...

Morgan Stanley analyst Terence Flynn raised the firm’s price target on Amgen (AMGN) to $330 from $328 and keeps an Equal Weight rating on the ...

With a label expansion for Uplizna pushing the drug into an untouched rare disease market, Amgen is getting its money’s worth out of another drug from its $27.8 billion Horizon Therapeutics buy.